ASCENDIS HEALTH LIMITED - Disclosure of acquisition of securities and dealings in securities by associates of a director

Disclosure of acquisition of securities and dealings in securities by associates of a director

Ascendis Health Limited
(Registration number 2008/005856/06)
(Incorporated in the Republic of South Africa)
Share code: ASC
ISIN: ZAE000185005
("Ascendis Health" or "the Company")


DISCLOSURE OF ACQUISITION OF SECURITIES AND DEALINGS IN SECURITIES BY
ASSOCIATES OF A DIRECTOR


DISCLOSURE OF ACQUISITION OF SECURITIES

1.     Shareholders are referred to the joint firm intention announcement released on the Stock Exchange
       News Service on Monday, 27 November 2023, regarding the potential offer by a consortium, led
       by ACN Capital IHC (Pty) Limited, to acquire all the shares in the Company (excluding treasury
       shares and shares already held by the consortium) by way of the voluntary exit offer and the
       delisting of Ascendis.

2.     In accordance with regulation 98(3) of the Companies Regulations, 2011, as amended,
       ("Regulations"), shareholders are hereby advised that the Company has received notification
       from:

2.1.     Dendrobium Capital Proprietary Limited ("Dendrobium"), advising that it acquired an additional
         1 265 000 ordinary shares in the issued share capital of the Company on 12 December 2023
         for a maximum price per share of R0.80, following which the total of all interests held by
         Dendrobium in the Company amounts to 6.07% of the Company's total issued share capital,
         excluding treasury shares;

2.2.     Carl Andre Capital Proprietary Limited ("Carl Andre Capital"), advising that it acquired an
         additional 2 530 000 ordinary shares in the issued share capital of the Company on 12
         December 2023 for a maximum price per share of R0.79, following which the total of all interests
         held by Carl Andre Capital in the Company amounts to 1.12% of the Company's total issued
         share capital, excluding treasury shares;

2.3.     Kingston Kapitaal Proprietary Limited ("Kingston Kapitaal"), advising that it acquired an
         additional 1 898 000 ordinary shares in the issued share capital of the Company on 12
         December 2023 for a maximum price per share of R0.79, following which the total of all interests
         held by Kingston Kapitaal in the Company amounts to 2.4% of the Company's total issued share
         capital, excluding treasury shares; and

2.4.     Blee Beleggings Proprietary Limited ("Blee Beleggings"), advising that it acquired an additional
         1 265 000 ordinary shares in the issued share capital of the Company on 12 December 2023
         for a maximum price per share of R0.79, following which the total of all interests held by Blee
         Beleggings in the Company amounts to 1.41% of the Company's total issued ordinary share
         capital, excluding treasury shares;

         (collectively referred to as "the Acquisitions")

3.     The requisite notice in terms of Regulation 98 has been filed with the Takeover Regulation Panel
       in accordance with Regulation 98(2) in respect of the Acquisitions.

DEALINGS IN SECURITIES BY ASSOCIATES OF A DIRECTOR

In compliance with paragraphs 3.63 to 3.74 of the Listings Requirements of the JSE Limited, the
following information regarding the dealings in securities is disclosed:

Name of director                                 Carl Neethling

Name of company of which the director is a       Ascendis Health Limited
director

Date of transactions                             12 December 2023 (1)

                                                 12 December 2023 (2)

                                                 12 December 2023 (3)

                                                 12 December 2023 (4)

Price per security (Cents)                       Low: 79       (1)

                                                 High: 80

                                                 VWAP: 79.9

                                                 79            (2)

                                                 79            (3)

                                                 79            (4)

Number of securities                             1 265 000     (1)

                                                 2 530 000     (2)

                                                 1 898 000     (3)

                                                 1 265 000     (4)

Total rand value of securities                   R1 011 032.70 (1)

                                                 R1 998 700    (2)

                                                 R1 499 420    (3)

                                                 R 999 350     (4)

Class of securities                              Ordinary shares

Nature of transactions                           Purchase of shares by an associate of the
                                                 director (on-market transaction) (1) – (4)

Nature and extent of directors interest in the   Indirect, beneficial (1) – (4)
transactions

Name of associates                               Dendrobium Capital (1)

                                                 Carl Andre Capital (2)

                                                 Kingston Kapitaal  (3)
                                                   
                                                 Blee Beleggings    (4)

Relationship with director                       Director is a director of the associate and
                                                 a beneficiary of a trust that is the
                                                 shareholder of the associate            (1)

                                                 Director is a director of the associate and
                                                 a beneficiary of a trust that is the
                                                 shareholder of the associate            (2)

                                                 Director is a director of the associate (3)

                                                 Director is a director of the associate (4)



Clearance for the above was obtained in terms of paragraph 3.66 of the JSE Limited Listings
Requirements.

The independent board and the board of the Company, collectively and individually, accept
responsibility for the information contained in this announcement and certify that, to the best of their
knowledge and belief, the information contained in this announcement accurately reflects the
information contained in the TRP 98 form received by the Company and is true, and that this
announcement does not omit anything that is likely to affect the importance of such information.


Johannesburg
14 December 2023


Sponsor
Valeo Capital (Pty) Ltd

Date: 14-12-2023 04:47:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.